2007;298:765 75. 231. Weiner DE, Tighiouart H, Stark PC, et al. Kidney disease as a risk factor for recurrent cardiovascular disease and mortality. Am J Kidney Dis. 2004;44:198 206. 232. Sachdev M, Sun JL, Tsiatis AA, et al. The prognostic importance of comorbidity for mortality in patients with stable coronary artery disease. J Am Coll Cardiol. 2004;43:576 82. 233. Hlatky MA. Comorbidity and outcome in patients with coronary artery disease. J Am Coll Cardiol. 2004;43:583 4. 234. Chirinos JA, Veerani A, Zambrano JP, et al. Evaluation of comorbidity scores to predict all-cause mortality in patients with established coronary artery disease. Int J Cardiol. 2007;117:97 102. 235. Rozanski A, Blumenthal JA, Kaplan J. Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy. Circulation. 1999;99:2192 217. 236. Denollet J, Pedersen SS, Vrints CJ, et al. Usefulness of type D per- sonality in predicting five-year cardiac events above and beyond con- current symptoms of stress in patients with coronary heart disease. Am J Cardiol. 2006;97:970 3. 237. Berkman LF, Blumenthal J, Burg M, et al. Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial. JAMA. 2003;289: 3106 16. 238. Glassman AH, O Connor CM, Califf RM, et al. Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA. 2002;288:701 9. 239. Ruo B, Rumsfeld JS, Hlatky MA, et al. Depressive symptoms and health-related quality of life: the Heart and Soul Study. JAMA. 2003; 290:215 21. 240. Rumsfeld JS, Magid DJ, Plomondon ME, et al. History of depression, angina, and quality of life after acute coronary syndromes. Am Heart J. 2003;145:493 9. 241. Rumsfeld JS, Jones PG, Whooley MA, et al. 